Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Birthistle

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Pediatric Surgery|September 1, 1995
Colonic atresia and spinal cord atrophy associated with a case of fetal varicella syndromeR Hitchcock, K Birthistle, D Carrington, et al.
BMJ (Clinical Research Ed.)|June 15, 1996
Secondary prevention of meningococcal disease. Ceftriaxone or ciprofloxacin should be considered as first line prophylaxisM J Martin, N A Hutchinson, I J Eltringham, et al.
International Journal of STD & AIDS|August 13, 2002
Seroepidemiological analysis of risk factors for herpes simplex virus type 2 infections in a genitourinary medicine clinic populationM J Slomka, K Birthistle, A J Vyse, et al.
Vox Sanguinis|April 26, 2006
Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemiaJ Björkander, J Nikoskelainen, H Leibl, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Pediatric Surgery|September 1, 1995
Colonic atresia and spinal cord atrophy associated with a case of fetal varicella syndromeR Hitchcock, K Birthistle, D Carrington, et al.
BMJ (Clinical Research Ed.)|June 15, 1996
Secondary prevention of meningococcal disease. Ceftriaxone or ciprofloxacin should be considered as first line prophylaxisM J Martin, N A Hutchinson, I J Eltringham, et al.
International Journal of STD & AIDS|August 13, 2002
Seroepidemiological analysis of risk factors for herpes simplex virus type 2 infections in a genitourinary medicine clinic populationM J Slomka, K Birthistle, A J Vyse, et al.
Vox Sanguinis|April 26, 2006
Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemiaJ Björkander, J Nikoskelainen, H Leibl, et al.
Pageof 2